The sales are too small relative to the $2.5B market cap to signal material insider concern. Monitor the next 8-K for any clinical data readout or pipeline update — likely catalyst for this biotech — but the insider trading itself offers no actionable signal.
Price Chart
Executive Summary
Nurix Therapeutics chief legal and scientific officers sold $688K in stock, including a single-day CLO sale of $581K. The cluster is small relative to the $2.5B market cap (0.03%) and fits a common vesting/exercise pattern — the legal officer exercised 22,016 derivative shares at $0-$8.72 alongside her sales. The dollar value is well below materiality thresholds and the sales pattern is consistent with tax-planning liquidity, not informed bearish conviction.
Key Financial Metrics
Key Facts
- Two C-suite insiders sold a total of ~34,300 shares across two dates
- Total open-market sale value is $688K, or ~0.03% of $2.5B market cap
- CLO exercised 22,016 derivative shares for $60K (mostly non-cash), then sold a portion
- CSO sold 5,400 shares for $108K on June 25
- No 10b5-1 plans or routine pattern data visible, but the structure is typical of vesting-and-sell-to-cover
- Prior 30-day insider activity showed 3 sales totaling $948K — this cluster continues a modest cadence
Financial Impact
Open-market sales of ~$688K, representing ~0.03% of market cap
Risk Factors
- No drug products approved — clinical-stage biotech binary risk
- Cash burn for R&D may require future equity financing, diluting current holders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NRIX-1783029804676 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 29d ago | Insider Cluster | $25.32 $25.10 | ▼ −0.87% | ▲ +0.28% | $22.89 (−9.60%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.22 $27.19 | ▲ +7.81% | ▲ +6.60% | $22.89 (−9.24%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.12 $26.63 | ▲ +6.01% | ▲ +5.66% | $22.89 (−8.88%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.12 $26.63 | ▲ +6.01% | ▲ +5.66% | $22.89 (−8.88%) |
Aug 3, 2026 8w ago | Insider Cluster | $24.69 $25.96 | ▲ +5.14% | ▲ +5.24% | $22.89 (−7.29%) |
Jul 30, 2026 9w ago | Insider Cluster | $23.21 $25.53 | ▲ +10.00% | ▲ +6.48% | $22.89 (−1.38%) |
Jul 9, 2026 12w ago | Press Release | $23.06 $23.07 | ▲ +0.04% | ▲ +0.60% | $22.89 (−0.74%) |
Jul 2, 2026 13w ago | Insider Cluster | $23.97 $24.69 | ▲ +3.00% | ▲ +2.07% | $22.89 (−4.51%) |
Jun 11, 2026 16w ago | Institutional Cluster | $16.98 $17.12 | ▲ +0.82% | ▲ +0.39% | $22.89 (+34.81%) |
Jun 8, 2026 16w ago | 8-K | $15.64 $17.04 | ▲ +8.95% | ▲ +6.84% | $22.89 (+46.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access